Table 4.
Number of US adults, in millions, meeting the definition for hypertension and the definition for treatment with antihypertensive medication according to the 2017 ACC/AHA guideline and the JNC7 guideline based on the 2011–2014 National Health and Nutrition Examination Survey.
| 2017 ACC/AHA guideline | JNC7 guideline | Difference (2017 ACC/AHA vs. JNC7) | ||||
|---|---|---|---|---|---|---|
| Hypertension | Recommended antihypertensive medication |
Hypertension | Recommended antihypertensive medication |
Hypertension | Recommended antihypertensive medication |
|
| Overall | 103.3 (92.7, 114.0) | 81.9 (73.8, 90.1) | 72.2 (65.3, 79.1) | 77.7 (70.0, 85.5) | 31.1 (26.6, 35.6) | 4.2 (3.3, 5.1) |
| Age group | ||||||
| 20–44 | 24.7 (21.6, 27.9) | 12.9 (11.3, 14.4) | 10.9 (9.6,12.2) | 12.6 (11.1, 14.1) | 13.9 (11.7, 16.0) | 0.3 (0.1, 0.5) |
| 45–54 | 20.1 (17.7, 22.6) | 14.3 (12.6, 15.9) | 12.6 (11.2,14.0) | 14.0 (12.4, 15.6) | 7.5 (5.9, 9.1) | 0.3 (0.1, 0.4) |
| 55–64 | 26.2 (22.4, 30.0) | 22.9 (19.6, 26.2) | 20.6 (17.7,23.5) | 21.6 (18.5, 24.7) | 5.6 (4.2, 6.9) | 1.3 (0.7, 1.8) |
| 65–74 | 18.5 (16.1, 20.9) | 18.1 (15.9, 20.4) | 15.6 (13.5,17.6) | 16.4 (14.3, 18.4) | 2.9 (2.1, 3.8) | 1.8 (1.1, 2.4) |
| 75+ | 13.8 (11.7, 15.8) | 13.8 (11.7, 15.8) | 12.6 (10.9, 14.3) | 13.1 (11.2, 15.1) | 1.2 (0.8, 1.6) | 0.6 (0.4, 0.9) |
| Men | 52.8 (46.6, 59.1) | 40.6 (35.7, 45.5) | 34.8 (30.6, 39.0) | 37.9 (33.2, 42.6) | 18.1 (15.3, 20.8) | 2.7 (2.0, 3.4) |
| Women | 50.5 (45.4, 55.6) | 41.4 (37.6, 45.1) | 37.4 (34.1, 40.8) | 39.9 (36.2, 43.5) | 13.1 (10.8, 15.4) | 1.5 (0.9, 2.1) |
| Race-ethnicity | ||||||
| Non-Hispanic white | 70.8 (58.3, 83.3) | 56.8 (47.1, 66.4) | 50.1 (41.7, 58.4) | 53.5 (44.4, 62.7) | 20.7 (16.0, 25.4) | 3.2 (2.2, 4.2) |
| Non-Hispanic black | 14.3 (11.3, 17.2) | 11.6 (9.2, 14.1) | 10.7 (8.4, 12.9) | 11.3 (8.9, 13.7) | 3.6 (2.8, 4.4) | 0.3 (0.2, 0.5) |
| Non-Hispanic Asian | 4.4 (3.5, 5.3) | 3.3 (2.6, 4.1) | 2.9 (2.3, 3.6) | 3.2 (2.5, 3.9) | 1.5 (1.1, 1.8) | 0.1 (0.0, 0.2) |
| Hispanic | 11.3 (8.4, 14.2) | 8.4 (6.0, 10.8) | 6.9 (4.8, 9.0) | 8.0 (5.7, 10.3) | 4.4 (3.4, 5.3) | 0.4 (0.2, 0.5) |
| Risk categories | ||||||
| <5% | 38.2 (33.6, 42.7) | 20.4 (18.0, 22.8) | 18.4 (16.2, 20.6) | 20.4 (18.0, 22.8) | 19.8 (16.9, 22.6) | 0 |
| 5% to <10% | 17.1 (14.3, 19.9) | 13.5 (11.3, 15.7) | 11.9 (9.9, 14.0) | 13.0 (11.0, 15.1) | 5.2 (3.8, 6.6) | 0.5 (0.1, 0.9) |
| 10% to <20% | 17.5 (15.3, 19.8) | 17.5 (15.3, 19.8) | 14.3 (12.4, 16.1) | 15.3 (13.4, 17.3) | 3.3 (2.3, 4.3) | 2.2 (1.5, 2.9) |
| ≥20% | 16.1 (13.8, 18.5) | 16.1 (13.8, 18.5) | 14.6 (12.5, 16.7) | 15.3 (13.0, 17.7) | 1.6 (1.2, 1.9) | 0.8 (0.6, 1.1) |
| History of CVD | 14.3 (12.6, 16.1) | 14.3 (12.6, 16.1) | 13.0 (11.4, 14.7) | 13.7 (12.0, 15.4) | 1.3 (0.8, 1.8) | 0.7 (0.3, 1.0) |
Numbers in table are number of US adults in millions (95% confidence interval)
2017 ACC/AHA guideline - 2017 American College of Cardiology/American Heart Association Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults.
JNC7 guideline - Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure
SBP – systolic blood pressure; DBP – diastolic blood pressure; CVD – cardiovascular disease.
See Table 1 for the definitions of hypertension and antihypertensive medication treatment recommendations.